World News

The company plans to execute this investment through two primary channels: expanding existing facilities and forging partnerships with local manufacturers.

Chile detected its final locally acquired leprosy case in 1993, meaning the country has maintained zero local transmission for more than three decades.

Philips’ cloud-enabled offering supports secure remote access to images, simplifies data management at scale, and facilitates enterprise integration and AI-enabled applications across health systems.

The NMPA based its approval decision on Phase III clinical trial data published in The Lancet Diabetes & Endocrinology in June 2025.

The facilities house 27 specialized production suites capable of manufacturing over 2 billion tablets and capsules annually, providing substantial capacity for both clinical and commercial-scale operations.

CSL plans to incorporate its Horizon 2 production process into the expanded facility, which the company describes as a cornerstone of its global manufacturing growth strategy.

By combining its global operations with Biocare’s established commercial presence across the United States, the company aims to reach a wider customer base and strengthen its market position.

The company also secured additional preferential participation in future exit proceeds, though these returns depend on Lone Star first recovering its initial equity investment.

Alfasigma will pay GSK USD 300 million upfront, with an additional USD 100 million due upon US Food and Drug Administration (FDA) approval.

SmartHeart can cut the number of required breath-holds for basic views by up to 75%, making the examination considerably more comfortable for those being scanned.